Drug Database
Back to search

France· FR:60626471

ROVALCYTE 50 mg/ml, poudre pour solution buvable

A valganciclovir product containing chlorhydrate de valganciclovir, registered in France by CHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE), on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC J05AB14

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedROVALCYTE 50 mg/ml, poudre pour solut…ATCJ05AB14REGISTER NO.FR:60626471PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about chlorhydrate de valganciclovirAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Valganciclovir is registered in 18 of 19 countries.

Countries holding a registration under ATC J05AB14 (valganciclovir), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 11 of them publish a price we can compare per daily dose
Search valganciclovir products by name

Valganciclovir · ATC J05AB14

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of valganciclovir costs, country by country.

Normalised to the WHO defined daily dose (0.9 g), the median price runs from $3.83 in United States to $35.27 in Italy — a ×9.2 gap.

  • France: $22.39 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Valganciclovir · price per daily dose (0.9 g)

USD · FX 28 Sept 2026

  • IT Italy$35.27
  • CH Switzerland$35.18
  • FR France$22.39
  • US United States$3.83 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CHLORHYDRATE DE VALGANCICLOVIR
Manufacturer
CHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE)
Country
France (FR)
ATC code
J05AB14
ATC class
Valganciclovir
Defined daily dose
0.9 g, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400938673371
    1 flacon(s) en verre brun avec fermeture de sécurité enfant de 12 g de poudre avec adaptateur(s) pour flacon polyéthylène basse densité (PEBD) avec 2 seringue(s) pour administration orale polypropylène polyéthylène
    EUR 243.38

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

283 interactions on record for valganciclovir.

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check valganciclovir against other medicinesHow interaction checks work

Valganciclovir · interactions on record

283 records

  • 8 severe
  • 193 moderate
  • 82 info

Most severe, free to view

  • CladribineL01BB04severe
  • TrospiumA03AB20moderate
  • Amphotericin BA07AA07moderate
  • TrospiumG04BD09moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Valganciclovir in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All valganciclovir products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Valcyte, Valganciclovir +pharma
  • Belgium · Valcyte, Valganciclovir Sandoz
  • Bulgaria · Алваноцит, Валцит
  • Cyprus · Valcyte, Valganciclovir Accord
  • Czechia · Cytevix, Valcyte
  • Germany · Valcyte, Valganaxiro
  • Denmark · Valcyte, Valganciclovir "medical Valley"
  • Estonia · Valganciclovir Accord, Valganciclovir Sandoz
  • Spain · Valcyte, Valganciclovir Accord
  • Finland · Valcyte, Valganciclovir Accord
  • United Kingdom (Northern Ireland) · Valcyte, Valganciclovir Accord Healthcare
  • Greece · Vagotrosin, Valcyte
  • Croatia · Alvanocyt, Valcyte
  • Hungary · Valcyte, Valdamin
  • Ireland · Valcyte, Valganciclovir Accord Healthcare
  • Iceland · Valcyte, Valganciclovir Medical Valley
  • Italy · Valcyte, Valganciclovir Accord
  • Lithuania · Valganciclovir Accord, Valganciclovir Sandoz
  • Luxembourg · Valcyte
  • Latvia · Valcyte, Valganciclovir Accord
  • Netherlands · Alvanocyt, Valcyte
  • Norway · Valcyte, Valganciclovir Accord
  • Poland · Ceglar, Valcyte
  • Portugal · Rovalcyte, Valganciclovir Accord
  • Romania · Valganciclovir Zentiva
  • Sweden · Valcyte, Valganciclovir Accord
  • Slovenia · Ganaxa, Valcyte
  • Slovakia · Valdamin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/06c76ac9-ac1e-472c-8c3f-cecf5e14ed39
GET /v1/drugs/06c76ac9-ac1e-472c-8c3f-cecf5e14ed39?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "60626471",
  "date_amm": "2008-07-02",
  "type_amm": "Procédure de reconnaissance mutuelle",
  "numero_ue": null,
  "substance": "CHLORHYDRATE DE VALGANCICLOVIR",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre pour solution buvable",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about valganciclovir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console